Concepedia

Richard Piekarz

RP

Statistics

Publications

83

Citations

6.2K

H-Index

40

Active since

1985

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

City Of Hope National Medical Center

City of Hope

Richard Piekarz is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1985–2025

83

Publications

83

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Richard Piekarz, Robin Frye, Maria L. Turner et al. · Journal of Clinical Oncology · 2009 · 737 citations · Full text

, , +17

Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.

Victor Sandor, Susan Bakke, Robert W. Robey et al. · PubMed · 2002 · 510 citations

, , +12

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

Richard Piekarz, Robin Frye, H. Miles Prince et al. · Blood · 2011 · 490 citations · Full text

, , +9

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report

Richard Piekarz, Robert W. Robey, Victor Sandor et al. · Blood · 2001 · 447 citations · Full text

, , +11

Cardiac Studies in Patients Treated with Depsipeptide, FK228, in a Phase II Trial for T-Cell Lymphoma

Richard Piekarz, A. Robin Frye, John J. Wright et al. · Clinical Cancer Research · 2006 · 234 citations

, , +14

1–5 of 83